Skip to content

HIV-associated immunosuppression increases risk of liver cancer

Antiretroviral therapy does not fully reverse impact of HIV on hepatitis C-related cirrhosis

Low rate of spontaneous hepatitis C clearance in patients with HIV; early HIV treatment recommended for those with chronic hepatitis C infection

Kidney disease risk increased for patients with HIV and hepatitis C

Fear and stigma creating hepatitis C transmission risk for HIV-positive gay men

Evidence to support belief in transmission of hepatitis C by sharing drug sniffing equipment

Efavirenz does not increase risk of depression in those taking hepatitis C treatment

Fibrosis linked to rapid loss of gut CD4 cells after HIV infection

Rapid progression of liver fibrosis in HIV-positive gay men recently infected with hepatitis C